142 related articles for article (PubMed ID: 22433804)
21. Developing a Consistent, Reproducible Botulinum Toxin Type A Dosing Method for Upper Limb Tremor by Kinematic Analysis.
Samotus O; Lee J; Jog M
Toxins (Basel); 2021 Apr; 13(4):. PubMed ID: 33917695
[TBL] [Abstract][Full Text] [Related]
22. [Botulinum toxin type A (dysport) in the complex rehabilitation of children with spastic forms of cerebral palsy].
Zmanovskaia VA; Levitina EV; Popkov DA; Butorina MN; Pavlova OL
Zh Nevrol Psikhiatr Im S S Korsakova; 2014; 114(7):33-6. PubMed ID: 25176264
[TBL] [Abstract][Full Text] [Related]
23. Essential palatal tremor treated with botulinum toxin.
Carman KB; Ozkan S; Yarar C; Yakut A
Pediatr Neurol; 2013 May; 48(5):415-7. PubMed ID: 23583064
[TBL] [Abstract][Full Text] [Related]
24. Botulinum Toxin in Parkinson Disease Tremor: A Randomized, Double-Blind, Placebo-Controlled Study With a Customized Injection Approach.
Mittal SO; Machado D; Richardson D; Dubey D; Jabbari B
Mayo Clin Proc; 2017 Sep; 92(9):1359-1367. PubMed ID: 28789780
[TBL] [Abstract][Full Text] [Related]
25. Isosorbide dinitrate ointment vs botulinum toxin A (Dysport) as the primary treatment for chronic anal fissure: a randomized multicentre study.
Berkel AE; Rosman C; Koop R; van Duijvendijk P; van der Palen J; Klaase JM
Colorectal Dis; 2014 Oct; 16(10):O360-6. PubMed ID: 24629060
[TBL] [Abstract][Full Text] [Related]
26. Botulinum toxin treatment of essential head tremor.
Pahwa R; Busenbark K; Swanson-Hyland EF; Dubinsky RM; Hubble JP; Gray C; Koller WC
Neurology; 1995 Apr; 45(4):822-4. PubMed ID: 7723978
[TBL] [Abstract][Full Text] [Related]
27. [Botulinum toxin treatment of hip adductor spasticity in multiple sclerosis].
Wissel J; Entner T
Wien Klin Wochenschr; 2001; 113 Suppl 4():20-4. PubMed ID: 15506048
[TBL] [Abstract][Full Text] [Related]
28. Development and validation of the vocal tremor scoring system.
Bové M; Daamen N; Rosen C; Wang CC; Sulica L; Gartner-Schmidt J
Laryngoscope; 2006 Sep; 116(9):1662-7. PubMed ID: 16955000
[TBL] [Abstract][Full Text] [Related]
29. More Evidence for Botulinum Toxin in Isolated or Essential Head Tremor.
Pandey S
Mov Disord Clin Pract; 2024 Apr; 11(4):335-336. PubMed ID: 38415504
[No Abstract] [Full Text] [Related]
30. Dynamic decomposition of motion in essential and parkinsonian tremor.
Rahimi F; Debicki D; Roberts-South A; Bee C; Bapat P; Jog M
Can J Neurol Sci; 2015 Mar; 42(2):116-24. PubMed ID: 25702954
[TBL] [Abstract][Full Text] [Related]
31. Dysport (botulinum toxin type A) in routine therapeutic usage: a telephone needs assessment survey of European physicians to evaluate current awareness and adherence to product labeling changes.
Hubble J; Schwab J; Hubert C; Abbott CC
Clin Neuropharmacol; 2013; 36(4):122-7. PubMed ID: 23783005
[TBL] [Abstract][Full Text] [Related]
32. Improvement in pelvic pain with botulinum toxin type A - Single vs. repeat injections.
Nesbitt-Hawes EM; Won H; Jarvis SK; Lyons SD; Vancaillie TG; Abbott JA
Toxicon; 2013 Mar; 63():83-7. PubMed ID: 23220489
[TBL] [Abstract][Full Text] [Related]
33. A double-blind, randomized, controlled study of botulinum toxin type A in MS-related tremor.
Van Der Walt A; Sung S; Spelman T; Marriott M; Kolbe S; Mitchell P; Evans A; Butzkueven H
Neurology; 2012 Jul; 79(1):92-9. PubMed ID: 22753445
[TBL] [Abstract][Full Text] [Related]
34. Real-World Longitudinal Experience of Botulinum Toxin Therapy for Parkinson and Essential Tremor.
Samotus O; Mahdi Y; Jog M
Toxins (Basel); 2022 Aug; 14(8):. PubMed ID: 36006219
[TBL] [Abstract][Full Text] [Related]
35. [Foot deformity in children with spastic forms of cerebral palsy: the treatment with botulinum toxin type A (dysport)].
Kurenkova AL; Dutikova EM; Nikitin SS; Artemenko AR
Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(6):37-43. PubMed ID: 20559272
[TBL] [Abstract][Full Text] [Related]
36. Clinical characteristics of essential voice tremor: a study of 34 cases.
Sulica L; Louis ED
Laryngoscope; 2010 Mar; 120(3):516-28. PubMed ID: 20066728
[TBL] [Abstract][Full Text] [Related]
37. Interarytenoid muscle botox injection for treatment of adductor spasmodic dysphonia with vocal tremor.
Kendall KA; Leonard RJ
J Voice; 2011 Jan; 25(1):114-9. PubMed ID: 20137891
[TBL] [Abstract][Full Text] [Related]
38. Essential tremor in the older adult: coping with primary symptoms.
Luggen AS;
Adv Nurse Pract; 2004 Sep; 12(9):32-6. PubMed ID: 15473446
[No Abstract] [Full Text] [Related]
39. [Focal dystonias and their treatment with dysport (botulinum toxin type A)].
Orlova OR; Timerbaeva SL; Khat'kova SE; Kotliarov VV; Korenko LA; Zalialova ZA; Fal'kovskiĭ IV; Shperling LP; Antipova LN; Antipenko EA; Mingazova LR; Soĭkher MI; Krasavina DA
Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(5):81-9. PubMed ID: 22951787
[No Abstract] [Full Text] [Related]
40. Clostridium botulinum type A toxin for the treatment of upper face animation lines: an Iranian experience.
Farahvash MR; Arad S
J Cosmet Dermatol; 2007 Sep; 6(3):152-8. PubMed ID: 17760691
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]